Alan Cass
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alan Cass has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Cilla Preece
2 shared publicationsJeannie Devitt
Menzies School of Health Research and Institute of Advanced Studies|Charles Darwin University
2 shared publicationsJoan Cunningham
Menzies School of Health Research and Institute of Advanced Studies|Charles Darwin University
2 shared publicationsJosette Eris
Central Clinical School|University of Sydney|Statewide Renal Services|Royal Prince Alfred Hospital|Cooperative Research Centre for Aboriginal Health
2 shared publicationsKate Anderson
2 shared publicationsPaul Snelling
2 shared publications
Latest Publications
- Open Access
- 20 February 2006
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (5) , 1178-1183
Australian nephrologists' attitudes towards living kidney donation
Background. The demand for deceased donor kidneys far outweighs the supply. The rate of living kidney donation (LKD) has been steadily increasing world-wide and is associated with excellent outcomes for the recipient. With respect to donors’ outcomes, however, a strong evidence base is lacking. This study explores the attitudes and perceptions of Australian nephrologists towards LKD, specifically regarding donor risk, their willingness to recommend LKD and their own preparedness to become a live donor. Methods. A postal survey of Australian nephrologists was conducted. Responses to six multiple choice questions about LKD were collected as a separate focus of a larger study. Results. We achieved a survey response rate of 52.4% and analysed responses from 184 practicing nephrologists and trainees. Australian nephrologists and trainees were generally supportive of LKD. The vast majority (95%) of respondents indicated that they would recommend it to a suitable donor or would themselves (97%) donate a kidney to an immediate family member. However, fewer than half (43%) would recommend LKD to a potential donor, where their relative's end-stage kidney disease (ESKD) had been attributed to diabetes and where there was a strong family history of diabetes. A minority thought that LKD increased the donor's risk of mortality (12%) or of ESKD (25%). Few nephrologists (4%) indicated their preparedness to be an altruistic donor – to a recipient unknown to them. Conclusions. Although LKD is clearly supported by the nephrologists, the increasing incidence of ESKD attributable to diabetes, now the leading cause of ESKD in Australia, might, however, progressively limit its use. Meeting the growing demand for kidney transplantation will require an increased supply of both live and deceased donor kidneys. We should develop, evaluate and implement best-practice approaches to achieve this.
- 20 February 2006
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (5) , 1178-1183
Open AccessAustralian nephrologists' attitudes towards living kidney donation
Background. The demand for deceased donor kidneys far outweighs the supply. The rate of living kidney donation (LKD) has been steadily increasing world-wide and is associated with excellent outcomes for the recipient. With respect to donors’ outcomes, however, a strong evidence base is lacking. This study explores the attitudes and perceptions of Australian nephrologists towards LKD, specifically regarding donor risk, their willingness to recommend LKD and their own preparedness to become a live donor. Methods. A postal survey of Australian nephrologists was conducted. Responses to six multiple choice questions about LKD were collected as a separate focus of a larger study. Results. We achieved a survey response rate of 52.4% and analysed responses from 184 practicing nephrologists and trainees. Australian nephrologists and trainees were generally supportive of LKD. The vast majority (95%) of respondents indicated that they would recommend it to a suitable donor or would themselves (97%) donate a kidney to an immediate family member. However, fewer than half (43%) would recommend LKD to a potential donor, where their relative's end-stage kidney disease (ESKD) had been attributed to diabetes and where there was a strong family history of diabetes. A minority thought that LKD increased the donor's risk of mortality (12%) or of ESKD (25%). Few nephrologists (4%) indicated their preparedness to be an altruistic donor – to a recipient unknown to them. Conclusions. Although LKD is clearly supported by the nephrologists, the increasing incidence of ESKD attributable to diabetes, now the leading cause of ESKD in Australia, might, however, progressively limit its use. Meeting the growing demand for kidney transplantation will require an increased supply of both live and deceased donor kidneys. We should develop, evaluate and implement best-practice approaches to achieve this.
- 6 December 2004
- Published by Wiley in Nephrology
- Vol. 9 (s4) , S144-S146
Barriers to access by Indigenous Australians to kidney transplantation: The IMPAKT study
SUMMARY: Although Indigenous Australians represent less than 2% of the national population, they account for 8–10% of new patients commencing treatment for end‐stage renal disease (ESRD). Almost half come from remote regions lacking renal disease treatment services. In those regions, their incidence of ESRD is up to 30 times the incidence for all Australians.Kidney transplantation is the optimal treatment for ESRD. Compared with long‐term dialysis, it results in better quality of life, longer life expectancy and lower costs of health care. Indigenous Australians with ESRD receive transplants at approximately one‐third the rate of non‐Indigenous patients. There are similar disparities in access to kidney transplants for Native Americans, Aboriginal Canadians and New Zealander Maori. The reasons for such disparities have not been studied in any detail.IMPAKT (Improving Patient Access to Kidney Transplantation) is an NHMRC‐funded study, involving eight major renal units. It aims to identify the reasons for Indigenous Australians’ poor access to transplantation. It will systematically examine each of the steps a new dialysis patient must negotiate in order to receive a transplant. Each of these steps can become a barrier.
- 6 December 2004
- Published by Wiley in Nephrology
- Vol. 9 (s4) , S144-S146
Barriers to access by Indigenous Australians to kidney transplantation: The IMPAKT study
SUMMARY: Although Indigenous Australians represent less than 2% of the national population, they account for 8–10% of new patients commencing treatment for end‐stage renal disease (ESRD). Almost half come from remote regions lacking renal disease treatment services. In those regions, their incidence of ESRD is up to 30 times the incidence for all Australians.Kidney transplantation is the optimal treatment for ESRD. Compared with long‐term dialysis, it results in better quality of life, longer life expectancy and lower costs of health care. Indigenous Australians with ESRD receive transplants at approximately one‐third the rate of non‐Indigenous patients. There are similar disparities in access to kidney transplants for Native Americans, Aboriginal Canadians and New Zealander Maori. The reasons for such disparities have not been studied in any detail.IMPAKT (Improving Patient Access to Kidney Transplantation) is an NHMRC‐funded study, involving eight major renal units. It aims to identify the reasons for Indigenous Australians’ poor access to transplantation. It will systematically examine each of the steps a new dialysis patient must negotiate in order to receive a transplant. Each of these steps can become a barrier.
- Open Access
- 14 September 2004
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 171 (6) , 597-598
Health outcomes in Aboriginal populations
Why do Aboriginal Canadian, Maori New Zealander, Aboriginal Australian and Native American babies born today share a pattern of premature morbidity and mortality rather than the expected healthy life-course of the nonindigenous baby in the next crib? Despite marked improvements in the average
- 14 September 2004
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 171 (6) , 597-598
Open AccessHealth outcomes in Aboriginal populations
Why do Aboriginal Canadian, Maori New Zealander, Aboriginal Australian and Native American babies born today share a pattern of premature morbidity and mortality rather than the expected healthy life-course of the nonindigenous baby in the next crib? Despite marked improvements in the average